Abstract
To enhance the practical application of intestinal organoids, it is imperative to establish standardized guidelines. This proposed standardization outlines a comprehensive framework to ensure consistency and reliability in the development, characterization, and application of intestinal organoids. The recommended guidelines encompass crucial parameters, including culture conditions, critical quality attributes, quality control measures, and functional assessments, aimed at fostering a standardized approach across diverse research initiatives. The implementation of these guidelines is anticipated to significantly contribute to the reproducibility and comparability of results in the burgeoning field of intestinal organoid research.
Keywords:
guideline; human adult stem cell (hASC); human intestinal organoid (hIO); human pluripotent stem cell (hPSC); standardization.
Copyright © 2024 Lee, Yang, Lee, Kim, Jeong, Kim, Jung, Jeon, Kwon, Lee, Lee, Park, Ahn, Yoo and Son.
Grants and funding
The authors declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by a grant from the Korean Fund for Regenerative Medicine (KFRM) grant funded by the Korean government (Ministry of Science and ICT, Ministry of Health and Welfare, 21A0404L1), the grant (23212MFDS265) from Ministry of Food and Drug Safety in 2023, a grant (22213MFDS386) from Ministry of Food and Drug Safety in 2024, a grant of a grant (23192MFDS097) from Ministry of Food and Drug Safety in 2023, a grant from the Technology Innovation Program (20018578, Production standardization and development of analysis to verify the quality and characterization of organoid based regeneration medicine) funded By the Ministry of Trade, Industry and Energy (MOTIE, Korea), a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI22C1462) and the KRIBB Research Initiative Program (KGM4722432).